Literature DB >> 18561589

Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea.

James Q Del Rosso1, Joel Schlessinger, Philip Werschler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561589

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


× No keyword cloud information.
  20 in total

1.  Use of Oral Doxycycline for Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infections.

Authors:  Sanjay Bhambri; Grace Kim
Journal:  J Clin Aesthet Dermatol       Date:  2009-04

Review 2.  Rosacea: new and emerging treatments.

Authors:  Farah A Moustafa; Laura F Sandoval; Steven R Feldman
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 3.  [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies].

Authors:  A Sobottka; P Lehmann
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

4.  Chronic treatment with a broad-spectrum metalloproteinase inhibitor, doxycycline, prevents the development of spontaneous aortic lesions in a mouse model of vascular Ehlers-Danlos syndrome.

Authors:  Hyun-Jin Tae; Shannon Marshall; Jing Zhang; Mingyi Wang; Wilfried Briest; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2012-07-19       Impact factor: 4.030

Review 5.  Rosacea Management.

Authors:  Manal Abokwidir; Steven R Feldman
Journal:  Skin Appendage Disord       Date:  2016-05-18

6.  Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome.

Authors:  Wilfried Briest; Timothy K Cooper; Hyun-Jin Tae; Melissa Krawczyk; Nazli B McDonnell; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

7.  [Ocular rosacea].

Authors:  B Sobolewska; M Zierhut
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

8.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

9.  Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

Review 10.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.